SMTL ID : 9fzs.1

Wild-type EGFR in complex with non-covalent poziotinib analogue

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

monomer

Ligands

1 x 01: 1-[(3~{R})-3-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-7-methoxy-quinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one

01.1: 24 residues within 4Å: Chain A: L.25, G.26, S.27, F.30, T.32, V.33, A.50, K.52, E.69, M.73, L.95, I.96, T.97, Q.98, L.99, M.100, P.101, F.102, G.103, C.104, D.107, L.151, T.161, D.162 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.25, A:F.30, A:V.33, A:T.97, A:L.151 Hydrogen bonds: A:M.100, A:M.100 Halogen bonds: A:L.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Waring, M., Insights into structure-reactivity-activity relationships for covalent inhibitors from profiling the EGFR activity of poziotinib analogues. To Be Published

Release Date

2025-07-16

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence